Monoclonal antibody against the fusion junction of a deletion-mutant epidermal growth factor receptor.

[1]  R. McLendon,et al.  Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. , 1995, Cancer research.

[2]  E. Baba,et al.  A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies. , 1995, Journal of immunology.

[3]  D. Bigner,et al.  Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas. , 1993, Cancer research.

[4]  P. Humphrey,et al.  Investigation of a synthetic peptide as immunogen for a variant epidermal growth factor receptor associated with gliomas , 1993, Journal of Neuroimmunology.

[5]  C. James,et al.  Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. Humphrey,et al.  Structural alterations of the epidermal growth factor receptor gene in human gliomas. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[7]  P. Humphrey,et al.  Deletion-mutant epidermal growth factor receptor in human gliomas: effects of type II mutation on receptor function. , 1991, Biochemical and biophysical research communications.

[8]  P. Humphrey,et al.  Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. , 1990, Cancer research.

[9]  C. James,et al.  Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Shibuya,et al.  A Deletion Mutation within the Ligand Binding Domain Is Responsible for Activation of Epidermal Growth Factor Receptor Gene in Human Brain Tumors , 1990, Japanese journal of cancer research : Gann.

[11]  P. Humphrey,et al.  Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[12]  R. Ueda,et al.  Nuclear localization of antigens detected by a monoclonal antibody against a synthetic peptide of rfp finger protein. , 1990, Hybridoma.

[13]  R. Ueda,et al.  A Human Monoclonal Antibody Recognizing a Surface Antigen on Stomach Cancer Cells , 1989, Japanese journal of cancer research : Gann.

[14]  J. Berzofsky,et al.  Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes. , 1989, Journal of immunology.

[15]  U. Bergerheim,et al.  Deletion mapping in human renal cell carcinoma. , 1989, Cancer research.

[16]  C. James,et al.  Clonal genomic alterations in glioma malignancy stages. , 1988, Cancer research.

[17]  P. Humphrey,et al.  Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts. , 1988, Cancer research.

[18]  M. Shibuya,et al.  Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors , 1988, Molecular and cellular biology.

[19]  K. Kinzler,et al.  Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Jensenius,et al.  A method for the blocking of endogenous immunoglobulin on frozen tissue sections in the screening of human hybridoma antibody in culture supernatants. , 1987, Hybridoma.

[21]  G. Carpenter,et al.  Receptors for epidermal growth factor and other polypeptide mitogens. , 1987, Annual review of biochemistry.

[22]  R. Ueda,et al.  Human monoclonal antibody reactive to stomach cancer produced by mouse-human hybridoma technique. , 1986, Japanese journal of cancer research : Gann.

[23]  M. Seto,et al.  Two mouse monoclonal antibodies detecting two different epitopes of an activated lymphocyte antigen on adult T-cell leukemia cells. , 1985, Cancer research.

[24]  T. Libermann,et al.  Expression of epidermal growth factor receptors in human brain tumors. , 1984, Cancer research.

[25]  M. Tanimoto,et al.  Production of monoclonal antibodies against MM antigen: the serologic identification of MM antigen with Ly-6.2 alloantigen. , 1982, Journal of immunology.

[26]  P. Goodfellow,et al.  A monoclonal antibody to the human epidermal growth factor receptor , 1982, Journal of cellular biochemistry.

[27]  L. Old,et al.  Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Fagraeus,et al.  Mixed haemadsorption: a mixed antiglobulin reaction applied to antigens on a glass surface. Preparation and evaluation of indicator red cells; survey of present applications. , 1965, Immunology.